BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/EED/Compounds

Compounds That Target EED

embryonic ectoderm development · 4 compounds in BiohacksAI corpus

EED (embryonic ectoderm development) is a biological target with 4 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into EED modulation for therapeutic and biohacking applications.

View EED target page →UniProt: O75530 ↗
Most Studied Compounds for EED
1
Astemizole
280+
studies
All 4 Compounds — Ranked by Evidence
1
Epigalocatechin Gallate
5.40
confidence
2
Tazemetostat
3.78
confidence
3
Wedelolactone
3.00
confidence
4
Astemizole
280+
studies
1.10
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for EED (embryonic ectoderm development). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: EED target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.